80 related articles for article (PubMed ID: 3592710)
41. [Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy].
Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Oshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
Hinyokika Kiyo; 1990 Mar; 36(3):285-93. PubMed ID: 2191570
[TBL] [Abstract][Full Text] [Related]
42. [Antiandrogenic treatment of pain caused by bone metastasis of carcinoma of the prostate (author's transl)].
Kawai T
Rinsho Hoshasen; 1979; 24(10):1029-34. PubMed ID: 502053
[No Abstract] [Full Text] [Related]
43. Treatment of metastatic prostate adenocarcinoma to the calcaneus.
Bibbo C; Hatfield SP; Albright JT
J Foot Ankle Surg; 2010; 49(2):159.e15-20. PubMed ID: 20015665
[TBL] [Abstract][Full Text] [Related]
44. [Trepanobiopsy of the iliac bone in the diagnosis of bone metastasis of prostate carcinoma and in control of the efficacy of estrogen therapy].
Mazin VV; Komarova LI; Mazina NM
Urol Nefrol (Mosk); 1977; (3):41-2. PubMed ID: 878087
[No Abstract] [Full Text] [Related]
45. [Trends in patterns of care for prostatic cancer in Japan: statistics of 9 institutions for 5 years].
Akakura K; Isaka S; Fuse H; Akimoto S; Imai K; Yamanaka H; Akaza H; Niijima T; Moriyama N; Kawabe K
Hinyokika Kiyo; 1988 Jan; 34(1):123-9. PubMed ID: 3376793
[TBL] [Abstract][Full Text] [Related]
46. [Radiotherapy in the control of bone metastases in patients with adenocarcinoma of the prostate].
Milani F; Gramaglia A; Villa S
Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):45-7. PubMed ID: 1373914
[TBL] [Abstract][Full Text] [Related]
47. [An infrequent form of metastasis of carcinoma of the prostate].
Zabala Egurrola JA; Pertusa Peña C; Llarena Ibarguren R; Arruza Echevarría A; Arregui Erbina P; del Tanago JG
Arch Esp Urol; 1989 Oct; 42(8):796-8. PubMed ID: 2619348
[TBL] [Abstract][Full Text] [Related]
48. [Mandibular metastasis as the first manifestation of adenocarcinoma of the prostate].
Eres Sáez FJ; Camps C; Sarmentero Ortiz E; Colomer F; Zaragoza J
Actas Urol Esp; 1989; 13(4):274-5. PubMed ID: 2678938
[TBL] [Abstract][Full Text] [Related]
49. [Clinical effects of chemical hypophysectomy--instillation of ethanol into the pituitary on advanced prostatic carcinoma (author's transl)].
Takeuchi S; Tari K; Takeda F; Fujii T; Tozawa R
Nihon Hinyokika Gakkai Zasshi; 1980; 71(3):248-56. PubMed ID: 6156258
[No Abstract] [Full Text] [Related]
50. [Radiation recall dermatitis after oral cyclophosphamide].
Mievis C; Jansen N; Schleich F; Gennigens C; Rorive A; Jérusalem G; Fillet G; Sautois B
Rev Med Liege; 2009 Apr; 64(4):179-81. PubMed ID: 19514535
[TBL] [Abstract][Full Text] [Related]
51. Metastatic behavior of prostate cancer. Cluster analysis of patterns with respect to estrogen treatment.
de la Monte SM; Moore GW; Hutchins GM
Cancer; 1986 Aug; 58(4):985-93. PubMed ID: 3719562
[TBL] [Abstract][Full Text] [Related]
52. Isolated calcaneal metastasis from prostate cancer.
Agrawal S; Irvine A; Money-Kyrle J; Ellis BW
Ann R Coll Surg Engl; 2008 Apr; 90(3):W7-9. PubMed ID: 18430327
[TBL] [Abstract][Full Text] [Related]
53. Hypocalcemia associated with estrogen therapy for metastatic adenocarcinoma of the prostate.
Vogelgesang SA; McMillin JM
J Urol; 1988 Nov; 140(5):1025-7. PubMed ID: 3172354
[TBL] [Abstract][Full Text] [Related]
54. Carcinoma of prostate metastatic to breast.
Drelichman A; Amer M; Pontes E; Al-Sarraf M; Vaitkevicius VK
Urology; 1980 Sep; 16(3):250-5. PubMed ID: 7423701
[TBL] [Abstract][Full Text] [Related]
55. [Sequential estrogen and radiation therapy for stage C prostate cancer].
Tachibana Y; Kawai T; Kobayashi T; Yamauchi T; Aizawa T
Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):463-8. PubMed ID: 8515632
[TBL] [Abstract][Full Text] [Related]
56. Nuclear magnetic resonance in advanced prostate cancer (stage D).
Chéchile G; Zungri E; Mallo N; Sanz M; Setoain J; Díaz I; Valdés L
Urol Int; 1986; 41(4):279-83. PubMed ID: 3787850
[TBL] [Abstract][Full Text] [Related]
57. [Bone metastasis of prostatic adenocarcinoma. Image collection].
Torres-Gómez FJ; Vázquez-Ramírez FJ; Torres-Olivera FJ
Arch Esp Urol; 2015 Mar; 68(2):192-3. PubMed ID: 26550615
[No Abstract] [Full Text] [Related]
58. [Lytic bone metastasis in prostate cancer: a case report].
Mejía Ramírez de Arellano MV; Vállez Romero R; Romero Pisonero E; Zaragoza Brehscit C; Alcaraz López C
Rev Esp Geriatr Gerontol; 2018; 53(3):176-178. PubMed ID: 28734503
[No Abstract] [Full Text] [Related]
59. Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate.
Mooppan MM; Wax SH; Kim H; Wang JC; Tobin MS
J Urol; 1980 May; 123(5):694-6. PubMed ID: 7420557
[TBL] [Abstract][Full Text] [Related]
60. Hydroxyurea in stage D carcinoma of the prostate: a pilot study.
Lerner H; Malloy T; Cromie W; Longo S
J Urol; 1975 Sep; 114(3):425-9. PubMed ID: 1142528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
